PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-0.63%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-0.43%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-2.53%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-0.40%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
9.72%
Positive net income growth while ADI is negative. John Neff might see a big relative performance advantage.
10.53%
Positive EPS growth while ADI is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
10.71%
Positive diluted EPS growth while ADI is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.21%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.53%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
0.21%
Maintaining or increasing dividends while ADI cut them. John Neff might see a strong edge in shareholder returns.
-51.48%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-56.63%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
37.56%
10Y revenue/share CAGR at 50-75% of ADI's 73.46%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
18.56%
5Y revenue/share CAGR under 50% of ADI's 42.74%. Michael Burry would suspect a significant competitive gap or product weakness.
4.90%
3Y revenue/share CAGR under 50% of ADI's 11.04%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
58.74%
10Y OCF/share CAGR above 1.5x ADI's 31.24%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
56.76%
5Y OCF/share CAGR at 75-90% of ADI's 75.25%. Bill Ackman would push for operational improvements to match competitor’s mid-term gains.
14.75%
Positive 3Y OCF/share CAGR while ADI is negative. John Neff might see a big short-term edge in operational efficiency.
136.30%
Net income/share CAGR above 1.5x ADI's 35.80% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
100.76%
Positive 5Y CAGR while ADI is negative. John Neff might view this as a strong mid-term relative advantage.
26.23%
Positive short-term CAGR while ADI is negative. John Neff would see a clear advantage in near-term profit trajectory.
4.46%
Below 50% of ADI's 239.32%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
-16.33%
Negative 5Y equity/share growth while ADI is at 105.59%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-22.07%
Negative 3Y equity/share growth while ADI is at 84.72%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
647.52%
10Y dividend/share CAGR above 1.5x ADI's 171.45%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
165.01%
5Y dividend/share CAGR above 1.5x ADI's 46.28%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
80.30%
3Y dividend/share CAGR above 1.5x ADI's 28.78%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
22.53%
Our AR growth while ADI is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
0.10%
We show growth while ADI is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-4.08%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-12.98%
We have a declining book value while ADI shows 0.05%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
6.76%
Debt growth far above ADI's 0.03%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-2.33%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
1.21%
SG&A declining or stable vs. ADI's 28.73%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.